Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients With Advanced CML and Ph+ ALL on Immune Reconstitution and Lymphocyte Function
Biology of Blood and Marrow Transplantation- Netherlands
doi 10.1016/j.bbmt.2012.11.229
Full Text
Abstract
Available in
Date
February 1, 2013
Authors
Publisher
Elsevier BV